PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New breast cancer screening analysis confirms biennial interval optimal for average risk women

2015-04-21
(Press-News.org) WASHINGTON -- Results from a second comprehensive analysis of mammography screening, this time using data from digital mammography, confirms findings from a 2009 analysis of film mammography: biennial (every two years) screening offers a favorable balance of benefits to harm for women ages 50 to 74 who have an average risk of developing breast cancer.

A technical report of the analysis is posted on the US Preventive Services Task Force's website and is cited as one piece of evidence for its 2015 draft recommendations for breast cancer screening with mammography.

The new results represent a unanimous consensus of six independent modeling research teams from eight academic institutions that are part of CISNET, the NCI-funded Cancer Intervention and Surveillance Modeling Network, as well as researchers from the Breast Cancer Surveillance Consortium (BCSC).

The new CISNET/BCSC study used the six different simulation models to analyze 10 different digital breast cancer screening strategies for the U.S. female population with varying risk levels and competing causes of death other than breast cancer.

"No individual woman should base her decision on when to screen for breast cancer on these model findings," says the paper's lead author, Jeanne S. Mandelblatt, MD, MPH, of Georgetown Lombardi Comprehensive Cancer Center, a CISNET member. "We are modeling the population. The right answer about when to start screening and how often to have mammography will be determined individually, based on a woman's own risk and her preference for going through possible false positive tests. No model can provide answers to that.

"The tradeoff a woman is faced with is that every time she undergoes a screening test, she runs a risk of having a false-positive result that might lead to more testing and biopsies, or perhaps overtreatment," Mandelblatt says. "Overtreatment occurs when a women gets surgery, chemotherapy, and/or radiation for a cancer that is not destined to become life threatening."

The researchers used their models to examine screening strategies with different starting ages (40, 45 or 50), stopping ages, and one- or two-year intervals between screening exams. The modeling uses national data on breast cancer incidence, risks for breast cancer, mammography characteristics, treatment effects, and risk of dying from other diseases and then estimates the lifetime impact (outcomes including benefits and harms) of breast cancer screening mammography across the course of life.

The new analysis also incorporated four molecular subtypes of breast cancer based on hormone receptor and HER2 status, newer treatments, and information from digital screening and breast density. (Studies have suggested that women with dense breasts are more prone to cancer development. Tumors are also harder to find in dense tissue.)

Among the other modeling findings is that:

In an unscreened population, the models predict a median 12.9% cumulative probability of developing breast cancer from ages 40 to 100. Without screening, the median probability of dying of breast cancer is 2.5%.

If a particular screening strategy leads to a 30% reduction in breast cancer mortality, then the probability of breast cancer mortality would be reduced from 2.5% to 1.8% -- or 7.5 breast cancer deaths averted per 1000 women screened.

Screening biennially from ages 50-74 achieves a median 25.8% breast cancer mortality reduction -- averting 7 breast cancer deaths per 1000 women screened and leads to 953 false positives.

Biennial strategies maintain an average of 81.2% of annual screening benefits with almost half the false positives and fewer over-diagnosed cases. (Over-diagnosis occurs when the cancer is small and was never destined to become life threatening or because a woman can die of other illnesses before her breast cancer surfaces.)

Compared with biennial screening from ages 50-74, starting biennial screening at age 40 averts one more death from breast cancer and generates 576 more false positive tests and one more over-diagnosed cancer for every 1000 women screened.

Annual screening of average risk women would avert 3 more breast cancer deaths, but yields 1988 more false positives and 7 more over-diagnoses per 1000 women screened compared to screening every other year from 50-74.

For women with a two- to four-fold increase in breast cancer risk in their 40s compared with the average population in their age group, annual screening starting at age 40 or 45 would have a similar or more favorable harm to benefit ratio as biennial screening of average risk women from 50-74.

For women with even a 1.3-fold increase in risk (the level seen with high breast density or obesity, for example), biennial screening starting at age 40 would have similar ratios of harms to benefits as expected under biennial screening of average risk groups from ages 50-74.

For healthy older women who have an average of a 17-year remaining life expectancy, screening would be reasonable through age 78 or 80 and would have a minimal increase in over-diagnosis compared with stopping at age 74. However, for women with moderate to severe illnesses, screening cessation could occur at about age 68.

INFORMATION:

The study was supported by the National Institutes of Health/National Cancer Institute (U01 CA152958) and the National Cancer Institute-funded BCSC (P01 CA154292 and U54CA163303).

The writing committee for the technical report included: Mandelblatt, Natasha Stout, Clyde Schechter, Diana L. Miglioretti, Harry de Koning, and Kathleen Cronin.

Co-authors include: Aimee M. Near, Amanda Hoeffken and Yaojen Chang, of Georgetown Lombardi Comprehensive Cancer Center; Natasha K. Stout of Harvard Medical School; Clyde B. Schechter of Albert Einstein College of Medicine; Harry J. de Koning, Nicolien T. van Ravesteyn, Jeroen J. van den Broek and Eveline A. Heijnsdijk of Erasmus Medical Center, Rotterdam, Netherlands; Diana L. Miglioretti of the University of California, Davis; Martin Krapcho of Information Management Services (IMS), Calverton, Maryland; Amy Trentham-Dietz, Oguzhan Alagoz and Mehmet Ali Ergun and Ronald Gangnon of the University of Wisconsin; Anna N.A. Tosteson of the Geisel School of Medicine at Dartmouth University; Diego Munoz and Sylvia Plevritis of Stanford University; Sandra J. Lee and Hui Huang from Dana-Farber Cancer Institute and Harvard Medical School; Donald A. Berry, Gary Chisolm and Xuelin Huang of the University of Texas M.D. Anderson Cancer Center; Karla Kerlikowske of the University of California, San Francisco; Brian L. Sprague of the University of Vermont; Kathleen A. Cronin and Eric Feuer of the National Cancer Institute.

The authors report no potential financial conflicts.

About Georgetown Lombardi Comprehensive Cancer Center Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and MedStar Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Georgetown Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute (grant #P30 CA051008), and the only one in the Washington, DC area. For more information, go to http://lombardi.georgetown.edu.

About Georgetown University Medical Center Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health.



ELSE PRESS RELEASES FROM THIS DATE:

A bad buzz: Men with HIV need fewer drinks to feel effects

2015-04-21
New Haven, Conn. -- Researchers at Yale and the VA Pittsburgh Healthcare System compared the number of drinks that men with HIV infection, versus those without it, needed to get a buzz. They found that HIV-infected men were more sensitive to the effects of alcohol than uninfected men. The study published April 17 in the journal AIDS and Behavior. Researchers know that HIV and alcohol can make for a dangerous mix. "Alcohol makes it more likely you're going to get HIV due to risky sexual behavior," said Dr. Amy C. Justice, professor of medicine and public health at Yale. ...

Middle-aged congenital heart disease survivors may need special care

2015-04-20
DALLAS, April 20, 2015 -- For the first time, the American Heart Association has issued recommendations for healthcare providers treating people older than 40 with congenital heart disease. "People born with congenital heart disease are living longer and fuller lives than ever before, and there are now more adults than children with congenital heart disease," said Ami Bhatt, M.D., lead author of the new scientific statement published in the American Heart Association journal Circulation. "These patients often have a sense that their heart has been 'fixed' and they don't ...

New guideline on how to treat the 1 in 10 who experience a first seizure

2015-04-20
WASHINGTON, DC - In order to help doctors treat the millions of people who experience their first seizure each year, the American Academy of Neurology and the American Epilepsy Society have released a new guideline on how to treat a first seizure. The guideline is published in the April 21, 2015, print issue of Neurology®, the medical journal of the American Academy of Neurology (AAN), and will be presented at the AAN Annual Meeting in Washington, DC, April 18-25, 2015, which is the world's largest gathering of neurologists. One in 10 people worldwide have a first ...

Guideline authored by University of Maryland neurologist advises when to treat a first seizure

2015-04-20
WASHINGTON, DC, APRIL 20, 2015--A new guideline released today by the American Academy of Neurology (AAN) and the American Epilepsy Society (AES) found that administering an antiepileptic medication immediately after a first seizure reduces the risk of having another seizure within two years. The guideline, authored by Allan Krumholz, MD, a professor of neurology at the University of Maryland School of Medicine and physician at the Maryland Epilepsy Center at the University of Maryland Medical Center, is the first to address treatment of a first seizure in adults. A previous ...

DNA abnormalities found in children with chronic kidney disease

DNA abnormalities found in children with chronic kidney disease
2015-04-20
NEW YORK, NY (April 20, 2015) -- A significant proportion of children with chronic kidney disease (CKD) have unsuspected chromosomal imbalances, including DNA anomalies that have been linked to neurocognitive disorders, according to a new Columbia University Medical Center (CUMC) study. The findings suggest that routine genetic screening of children with CKD could lead to earlier and more precise diagnoses, as well as to more personalized monitoring, prevention, and treatment. Details of the study were published today in the online issue of the Journal of Clinical investigation. "With ...

New study unravels why common blood pressure medicine can fail

2015-04-20
Every year, more than 120 million prescriptions are written worldwide for thiazide drugs, a group of salt-lowering medicines used to treat high blood pressure. These drugs are often work very well, and over decades have saved hundreds of thousands of lives. But in some patients, thiazides are not effective; in others they lower blood pressure for a while and then stop working. The reasons for this have remained a mystery. Now, a new study by researchers at the University of Maryland School of Medicine (UM SOM) has revealed a key mechanism for this failure. Paul Welling, ...

New guidelines inform clinicians how to treat a first seizure

2015-04-20
Following a first seizure, physicians should discuss with patients whether it is appropriate to prescribe medication to reduce risk of another seizure, according to new guidelines released at the American Academy of Neurology meeting. The guidelines, which were a collaboration of authors at several North American medical institutions including NYU Langone Medical Center, found adults who experience a first seizure may have risk of another seizure that's greatest within the first two years. Adults with prior neurological trauma, abnormalities on EEGs and imaging may be ...

Notre Dame researchers detecting low quality antimalarial drugs with a lab-on-paper

2015-04-20
Access to high-quality medicine is a basic human right, but over four billion people live in countries where many medications are substandard or fake. Marya Lieberman of the Department of Chemistry and Biochemistry at the University of Notre Dame and Abigail Weaver a postdoctoral associate in the University's Department of Civil Engineering and Environmental and Earth Sciences took up the challenge of how people in developing countries could detect low quality antimalarial drugs without expensive equipment and without handling dangerous chemicals. The solution they ...

Better battery imaging paves way for renewable energy future

Better battery imaging paves way for renewable energy future
2015-04-20
MADISON, Wis. -- In a move that could improve the energy storage of everything from portable electronics to electric microgrids, University of Wisconsin-Madison and Brookhaven National Laboratory researchers have developed a novel X-ray imaging technique to visualize and study the electrochemical reactions in lithium-ion rechargeable batteries containing a new type of material, iron fluoride. "Iron fluoride has the potential to triple the amount of energy a conventional lithium-ion battery can store," says Song Jin, a UW-Madison professor of chemistry and Wisconsin Energy ...

Living life in the third person

2015-04-20
Toronto, CANADA - Imagine living a healthy, normal life without the ability to re-experience in your mind personal events from your past. You have learned details about past episodes from your life and can recite these to family and friends, but you can't mentally travel back in time to imagine yourself in any of them. Cognitive scientists from Baycrest Health Sciences' Rotman Research Institute in Toronto had a rare opportunity to examine three middle-aged adults (two from the U.S., the other from the U.K.) who essentially live their lives in the "third person" because ...

LAST 30 PRESS RELEASES:

For younger women, mental health now may predict heart health later

Missed opportunity: AEDs near cardiac arrests rarely used by bystanders

Eggs may not be bad for your heart after all

Alcohol raises heart disease risk, particularly among women

TTUHSC announces new center for nursing research

Adding just enough fuel to the fire

Impact of synbiotic supplements on the gut microbiome and overall health of penguins

Promising advances in organosilica membranes for separating organic liquid mixtures

Cell phone video technology unveils new method for analyzing walking and gait

Ancient isolation’s impact on modern ecology

Synaptic protein change during development offers clues on evolution and disease

How commercial rooftop solar power could bring affordable clean energy to low-income homes

Taking a closer look at pulmonary fibrosis genetics

Cats with MDR1 mutation at risk of severe reactions to popular medication

IOP Publishing and IPEM mandate reporting of sex and gender in research 

Dogs trained to detect trauma stress by smelling humans’ breath

Electronic device thermal management made simpler and slightly better!

Study: Dangerous surgical site infections can be reduced with simple prevention protocol

Genetic testing of patients with atrial fibrillation can alert clinicians to potential development of life-threatening conditions

Artificial Intelligence tool successfully predicts fatal heart rhythm

What progress has China made in agriculture green development over the past five years?

ALMA finds new molecular signposts in starburst galaxy

Open waste burning linked to air pollution in Northwestern Greenland

Google Street View reveals how built environment correlates with risk of cardiovascular disease

Connecting the dots to shape growth forces

Parental avoidance of toxic exposures could help prevent autism, ADHD in children, new study shows

Trends in the incidence of renal replacement therapy due to rapidly progressive glomerulonephritis in Japan, 2006–2021

Olympics not likely to swallow up skateboarding’s subversive nature into its corporate spectacle, study says

Looking after the NHS workforce must be a top priority, say experts

Prolonged use of certain hormone drugs linked to increased brain tumor risk

[Press-News.org] New breast cancer screening analysis confirms biennial interval optimal for average risk women